Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 9/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 8/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5250696 | 0.84 | HSD17B10 (0.42) | TSHRALOX15ALDH1A1MEN1MAPT | |
| SCHEMBL6018772 | 0.84 | HSD17B10 (0.42) | TSHRALOX15ALDH1A1MEN1MAPT | |
| SCHEMBL6019364 | 0.84 | ALDH1A1 (0.44) | CYP3A4CYP2C9TSHRMAPK1ALOX15 | |
| SCHEMBL6018783 | 0.71 | — | — | |
| SCHEMBL25868401 | 0.70 | ROCK2 (0.50) | CYP3A4CYP2C9CYP2C19TSHRMAPK1 | |
| SCHEMBL28831010 | 0.69 | RXFP1 (0.41) | CYP3A4CYP2C9CYP2C19TSHRMAPK1 | |
| SCHEMBL28831007 | 0.69 | RXFP1 (0.41) | CYP3A4CYP2C9CYP2C19TSHRMAPK1 | |
| SCHEMBL12235705 | 0.67 | RXFP1 (0.52) | TSHRMAPK1LMNAALDH1A1MEN1 | |
| SCHEMBL22554286 | 0.67 | RXFP1 (0.52) | TSHRMAPK1LMNAALDH1A1MEN1 | |
| SCHEMBL22554265 | 0.67 | RXFP1 (0.52) | TSHRMAPK1LMNAALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060228387-A1 | Dihydronepetalactams and N-substituted derivatives thereof | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060228387-A1 | Dihydronepetalactams and N-substituted derivatives thereof | NOTCH4, NRDC, BPHL | CYP3A4 879/4885CYP2C9 720/4885CYP2C19 1885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.